Valued at $186.0M at its later-stage round, Jan 2026. Nothing has traded since.
- ·The complete investor list: 12 names
- ·Watch Kinaset Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Kinaset Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2026 | Later Stage VC (Series B) | $103.0M | ▮ | ▮ |
| Jul 2022 | Early Stage VC | $28.5M | ▮ | ▮ |
| Jul 2020 | Seed Round | $1.5M | ▮ | ▮ |
Membership and data by Private Market View
Kinaset Therapeutics valuation
Kinaset Therapeutics was valued at $186 million at its later-stage round in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Kinaset Therapeutics raised?
Kinaset Therapeutics has raised $143 million across 3 recorded rounds since 2020. The largest was a $28.5 million early-stage round in Jul 2022; the most recent was a $103 million Series B in Jan 2026.
Kinaset Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Jul 2023 ($28.5 million sold to 3 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Plexium ($200 million), Ajax Therapeutics ($193 million) and Cambrian Bio ($180 million).
How Kinaset Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Kinaset Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Kinaset Therapeutics
- What is Kinaset Therapeutics worth?
- Kinaset Therapeutics is valued at $186.0M as of Oct 2026. Valued at $186.0M at its later-stage round, Jan 2026. Nothing has traded since.
- How much has Kinaset Therapeutics raised?
- Kinaset Therapeutics has raised $143.0M in total funding across 3 recorded rounds.
- When did Kinaset Therapeutics last raise?
- Kinaset Therapeutics last raised in Jan 2026 (Later Stage VC (Series B)), raising $103.0M.